SCHEMBL1708097

SCHEMBL1708097

CC(C(=O)O)[C@@H]1COc2cc(N(C(=O)C(F)(F)F)C3CCc4c(Br)cccc43)ccc21

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.33
DRD2 P14416 1/20 0.31
DRD1 P21728 1/20 0.31
DRD4 P21917 1/20 0.31
DRD5 P21918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1707702 0.87 LTB4R (0.30)
SCHEMBL1708570 0.87 LTB4R (0.30)
SCHEMBL10012574 0.83 FFAR1 (0.42)
SCHEMBL1708356 0.80 AKR1B1 (0.31)
SCHEMBL1708633 0.78 FFAR1 (0.42)
SCHEMBL1708578 0.76 KDM6B (0.32)
SCHEMBL1707861 0.75 LTB4R (0.31)
SCHEMBL1707739 0.74
SCHEMBL1708193 0.74
SCHEMBL1707982 0.74 FFAR1 (0.33) S1PR1DRD2DRD1DRD4DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440541-A1 NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2012-04-18 EP disclosed
WO-2010143733-A1 NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-12-16 WO disclosed